| Literature DB >> 18421383 |
Takeshi Yamamoto1, Norio Shibata, Masayuki Takashima, Shuichi Nakamura, Takeshi Toru, Nozomu Matsunaga, Hideaki Hara.
Abstract
The straightforward synthesis of both enantiomers of cis-5'-hydroxythalidomide, a major metabolite of thalidomide, has been accomplished by enzymatic kinetic resolution of a racemic substrate catalyzed by Pseudomonas stutzeri lipase TL. cis-5'-Hydroxythalidomide shows resistance to racemization (and epimerization) at physiological pH. A tube formation assay to assess the ability to inhibit angiogenesis revealed that cis-5'-hydroxythalidomides are inactive.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18421383 DOI: 10.1039/b802459f
Source DB: PubMed Journal: Org Biomol Chem ISSN: 1477-0520 Impact factor: 3.876